drugset / Trial / NCT04964544

Technology-Assisted Cholesterol Trial in Consumers (TACTiC)

NCT04964544

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this AUS is to evaluate the extent to which participants can safely and effectively self-select, purchase, and use Crestor OTC 5 mg for a 6-month period according to the label.

Timeline

Start
2021-07-08
Primary completion
2023-03-01
Completion
2023-03-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Rosuvastatin Small molecule 5 mg Oral